Macrophage Polarization States in the Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
The M1/M2 macrophage paradigm plays a key role in tumor progression. M1 macrophages are historically regarded as anti-tumor, while M2-polarized macrophages, commonly deemed tumor-associated macrophages (TAMs), are contributors to many pro-tumorigenic outcomes in cancer through angiogenic and lymphangiogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis. The tumor microenvironment (TME) can influence macrophage recruitment and polarization, giving way to these pro-tumorigenic outcomes. Investigating TME-induced macrophage polarization is critical for further understanding of TAM-related pro-tumor outcomes and potential development of new therapeutic approaches. This review explores the current understanding of TME-induced macrophage polarization and the role of M2-polarized macrophages in promoting tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that MSCs have the ability to polarize M1 pro-inflammatory macrophages towards an alternative M2 anti-inflammatory phenotype [21,22,23].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“These CD8+ T and NK cells express high levels of cytokines such as IFN-γ, GM-CSF, and TNF-α as well as chemokines such as CCL4, CCL5, and CCL23 that assist in the further recruitment of immune cells and the signaling of anti-tumorigenic pathways [73,74].”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 2×
“MDSCs express high levels of both iNOS and arginase-1, which both play a direct role in suppression of T-cell function [95].”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Inflammation can be triggered by conditions such as infection or injury or can be systemic as seen in type 2 diabetes and cardiovascular disease [59].”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 3×
“Current literature supports the theory that most TAMs originate from either tissueresident embryonic macrophages or macrophages derived from circulating monocytes that originate in the bone marrow [87].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 3×
“The significance of macrophage heterogeneity has been under review since the early 2000s and has been linked to many malignancies and autoimmune disorders in recent years [66].”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“The resolution of inflammation is led by the deactivation of these inflammatory mediators, permitting either the apoptosis of pro-inflammatory M1 macrophages or the transition to an anti-inflammatory M2 macrophage [64].”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 15×
“Macrophages are found in every human tissue in the body and exhibit anatomical and functional diversity [4].”
BackgroundInfluentialMurray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981 · cited 2×
“Some noncytokine, extrinsic pathways of macrophage polarization do exist, however, including hypoxia as well as the production of lactate within tumors, which drive M2 polarization [36].”
BackgroundFibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Cited by
Items 801–900 of 1,000
Cesca, B. A., Martin, K., & Ibarra, L. E. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010124 · Cited by 7
Regulating the regulators via targeting CD38 in the tumor microenvironment
Dutta, N., Halder, N., Chini, E. N., Kim, S., & Manna, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1745988 · Cited by 9
An Intracellular Gelated Macrophage-Based Vaccine for Tumor Immunotherapy
An, J., Tang, Y., He, J., Qin, Y., & Zhang, X. (2026) · ACS Nano · doi:10.1021/acsnano.5c17200 · Cited by 7
Ning, S., Wu, H., Guo, R., Deng, M., Cui, Y., Xue, D., Li, C., Jin, C., & Li, H. (2026) · Cancer Control · doi:10.1177/10732748261430581 · Cited by 9
“37 Non-coding RNAs, particularly long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), are increasingly recognized as critical regulators of the epithelial-mesenchymal transition (EMT) and TME dynamics during tumor progression.”
Development of a Macrophage-Related Risk Model for Metastatic Melanoma
Li, Z., Zhang, X., Jin, Q., Zhang, Q., Qi, Y., Fujimoto, M., & Jin, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813752 · Cited by 7
Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
Martynchyk, A., Chowdhury, R., Hawkes, E. A., & Keane, C. (2023) · Cancers · doi:10.3390/cancers15215217 · Cited by 7
“A shift from M1 to M2 and vice versa, or to a hybrid of both cells, is also possible under certain circumstances [58,59].”
BackgroundTan, S., Tang, H., Zhang, Z., Wang, Y., Li, H., Shi, W., Ye, H., Xie, P., & Zhou, J. (2024) · Clinical Medicine Insights Oncology · doi:10.1177/11795549241239042 · Cited by 7
Tominaga, M., Uto, T., Fukaya, T., Mitoma, S., Riethmacher, D., Umekita, K., Yamashita, Y., & Sato, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1200461 · Cited by 7
Magnolol’s Therapeutic Efficacy and Immunomodulatory Effects in Oral Squamous Cell Carcinoma
Tseng, C.-F., Chen, H.-M., Liao, T.-L., Hsu, F., Yeh, C., CHEN, W.-T., & Kok, S. (2024) · In Vivo · doi:10.21873/invivo.13678 · Cited by 7
“Additionally, tumor-associated macrophage (CD11b + / CD206 + ) was decreased by magnolol in SP and TIL as well (Figure 4B).”
InfluentialParekh, N. M., Desai, R. S., Bansal, S. P., Shirsat, P. M., & Prasad, P. S. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156742 · Cited by 7
Wang, X., Guo, J., & Dai, Q. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1492821 · Cited by 7
Santerre, J. P., Yang, Y., Du, Z., Wang, W., & Zhang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1492323 · Cited by 7
Wu, P., Chen, J., Li, H., Lu, H., Li, Y., & Zhang, J. (2024) · Oncology Reports · doi:10.3892/or.2024.8851 · Cited by 9
Park, J., Shin, J., Yang, H., Kim, T. H., Lee, S., Shin, O. S., & Park, I. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313097 · Cited by 7
The role and research progress of tumor-associated macrophages in cervical cancer
Wang, D., Han, X., & Liu, H. (2024) · American Journal of Cancer Research · doi:10.62347/ffxl7288 · Cited by 9
CAR-T Cell Therapy for Solid Tumors
Tony, L. T., Stabile, A., Schauer, M. P., Hudecek, M., & Weber, J. (2025) · Transfusion Medicine and Hemotherapy · doi:10.1159/000542438 · Cited by 11
“However, recent studies show that alternative signaling modules can alter the biological functions elicited by CAR-M, and the use of CD147 as a signaling domain induced matrix metalloproteinase expression and promoted tumor immune in fi ltration by ECM degradation [40, 130].”
Mahmoudian, M., Trotta, F., Raimondo, S., Bussolino, F., & Arese, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020503 · Cited by 7
“M2 macrophages employ various anti-inflammatory routes to aid cancer cells throughout their metastasis, angiogenesis, and proliferation [14].”
Zhang, C., Chen, Y.-Y., Chen, S., Wang, Y., Yuan, Y., Yang, X., Hu, W. M., Chen, B., Qi, Z., Huse, J. T., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2289 · Cited by 7
Chimeric antigen receptor-macrophages: Emerging next-generation cell therapy for brain cancer
Koppers, M. J. A., Monnikhof, M., Meeldijk, J., Koorman, T., & Bovenschen, N. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf059 · Cited by 9
“66 TAMs are traditionally classified into 2 main phenotypes: M1 and M2.”
Reprogramming and targeting of cholesterol metabolism in tumor-associated macrophages
Ma, Q., Zhu, Y., Zhang, D., Su, X., Jiang, C., Zhang, Y., Zhang, X., Han, N., Shu, G., Yin, G., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00236b · Cited by 7
Ding, H., Xue, L., Zhu, S., Wang, Z., Gui, H., Zhang, G., Tang, N., Ren, H., & Chen, D. (2025) · Smart Medicine · doi:10.1002/smmd.70009 · Cited by 9
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer
Skourti, E., Seip, K., Mensali, N., Jabeen, S., Juell, S., Øynebråten, I., Pettersen, S., Engebraaten, O., Corthay, A., Inderberg, E. M., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02082-x · Cited by 7
“This can be attributed to multiple reasons, such as high heterogeneity of the M2 MΦs [15] or lack of robust molecular signatures to distinguish the M2 phenotype [24].”
Persistent expression of NLRP3 in spinal microglia promotes development of lumbar disc degeneration
Wang, P., & Zhang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1064303 · Cited by 9
“It is known that the phenotypic adaptations of microglia during the initiation and progression of LDD are dynamic and involve not only changes in major functionality (M1 versus M2), but also some delicate changes in certain function such as phagocytotic, fibrotic, regenerative or else (18).”
BackgroundThapa, P., Jiang, H., Ding, N., Hao, Y., Alshahrani, A., Lee, E. Y., Fujii, J., & Wei, Q. (2023) · Antioxidants · doi:10.3390/antiox12030677 · Cited by 7
“In the context of the tumor microenvironment, M1 macrophages are considered antitumorigenic while M2 macrophages are considered immunosuppressive and protumorigenic [24].”
BackgroundGeng, Y., Sun, Y.-J., Song, H., Miao, Q., Wang, Y., Qi, J., Xu, X., & Sun, J. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s410723 · Cited by 7
“Past research highlighted its contribution to hypoxia induction, lymphangiogenic regulation, angiogenic, tumor cell proliferation, immune suppression, and metastasis.(47) These findings suggested that the 7 genes comprising the NLRs signature may influence SKCM patients’ prognosis by modulating the tumor immune microe…”
BackgroundChen, W., Guo, Q., Zhang, Y., Liu, Q., Zhang, Y., Zhao, C., Li, X., Bai, X., Zhang, L., & Shao, S. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13320 · Cited by 8
“17 It is generally considered that M1 macrophages play an antitumor role in the early stage of tumour progression.”
BackgroundDeng, Z., Guo, T., Bi, J., Wang, G., Hu, Y., Du, H., Zhou, Y., Jia, S., Xing, X., & Ji, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04473-0 · Cited by 8
“…are regarded as having an antitumor phenotype, and M2 macrophages have been reported to contribute to immune suppression and tumor cell metastasis [33–36], we inferred that, as the PTG score increases, macrophages are more inclined to be M2-polarized, leading to a more friendly microenvironment…”
BackgroundLahimchi, M. R., Maroufi, F., & Maali, A. (2023) · Cellular Reprogramming · doi:10.1089/cell.2023.0041 · Cited by 9
“In addition, we must consider the anti-immune M2 macrophages in TME, which promote tumor growth and metastasis (Boutilier and Elsawa, 2021).”
Zhang, Z., Zhang, A., Shi, Y., Zhao, Z., & Zhao, Z. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01714-5 · Cited by 7
“…et al. claimed that tumor-associated macrophages (TAMs), commonly known as m2-polarized macrophages, contributed to the development of tumors and played a vital role in angiogenic and lymphangi-ogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis [36].”
BackgroundXu, X., Su, Y., Pan, Y. J., Shen, M., Liu, D., Liu, Z., Chen, D., & Wu, J. H. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.15.8 · Cited by 7
“In response to various environmental sti - muli, they can adopt a pro-inflammatory M1 phenotype or an anti-inflammatory M2 phenotype (28,29).”
BackgroundAthanasiou, E., Papageorgiou, S., Dafni, M.-F., Kelesis, I., Vasileiou, M., Tatsiou, T., Kouveloglou, V., Kanatas, P., Stouras, I., Gatsis, A., et al. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673278897231229121524 · Cited by 8
Zhou, J., Liu, Y., Zhang, Y., Ling, F., Zheng, J., Yao, X., Lyu, Z., Feng, H., & Li, Y. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105315 · Cited by 7
Chen, R., Zheng, Y., Chen, F., Ye, J., & He, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-55919-4 · Cited by 7
Carvell, T., Burgoyne, P., Milne, L., Campbell, J. D. M., Fraser, A. R., & Bridle, H. L. (2024) · Journal of The Royal Society Interface · doi:10.1098/rsif.2023.0572 · Cited by 7
“It is increasingly apparent that these two classes of polarized macrophage play significant roles in a range of diseases such as cancers [66], liver diseases [67] and autoimmune disorders [68].”
Background[Tumor-associated Macrophage: Emerging Targets for Modulating the Tumor Microenvironment].
Zhou, Y., Ren, D., Bi, H., Yi, B., Zhang, C., Wang, H., & Sun, J. (2024) · PubMed Central · doi:10.3779/j.issn.1009-3419.2024.102.13 · Cited by 13
“…疫抑制程序性细胞死亡配体 1 ( programmed cell death ligand 1, PD-L1 )和细胞毒性 T 淋巴细胞抗原 4 ( cytotoxic T lymphocyte-associated antigen-4, CTLA4 )配体表达,从 而形成免疫抑制性微环境 [20] 。其次, M2 型巨噬细胞分泌 的一些促血管生成因子,包括 VEGF 、血小板源性生长因 子( platelet-derived growth factor, PDGF )、表皮生长因子 ( epidermal growth factor, EGF )、 TGF-β 、基质金属蛋白酶 2…”
Goonoo, N., Gimié, F., Aït-Arsa, I., Ziman, M. R., Adeyemi, S. A., Ubanako, P. N., Ngema, L. M., Choonara, Y. E., & Bhaw‐Luximon, A. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.213870 · Cited by 7
Xiao, X., Zheng, Y., Wang, T., Zhang, X., Fang, G., Zhang, Z., Zhang, Z., & Zhao, J. (2024) · Nanoscale Advances · doi:10.1039/d4na00079j · Cited by 9
Shivarudrappa, A. H., John, J., Vashisht, M., Ge, H., Liu, S., Chen, J., Siddoway, K., Dong, R., Chen, Z., & Wang, J. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405318 · Cited by 7
“M2-TAMs express a higher level of CD206 and can carry out immunosuppressive functions by expressing arginase-1 (Arg-1), chemoattractant such as IL-10 and TGF-b , and chemokine CCL17 and CCL22 (45).”
BackgroundMa, Q., Ma, F., Zhang, B., Zhang, Y., Peng, L., & Li, X. (2024) · Amino Acids · doi:10.1007/s00726-024-03404-7 · Cited by 7
“M1 macrophages mainly exhibit pro-inflammatory and anti-tumor effects, while M2 macrophages generally drive cancer progression and exert anti-inflammatory func - tions in cancers (Boutilier and Elsawa 2021).”
BackgroundCB2R activation enhances tumor-associated macrophages-mediated phagocytosis of glioma cell
Lu, S., Chen, X., Yang, Y., & Li, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40806 · Cited by 6
Geng, Y., DeLay, S. L., Chen, X., & Miska, J. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413273 · Cited by 10
Ding, J., Zhou, H., Huang, Y.-F., Peng, J., Huang, H., Hao, Y., Zong, Z., & Ning, Z. (2022) · Biomolecules · doi:10.3390/biom12121877 · Cited by 8
“Considering the two subtypes of mac ophages in the TME [21], we also analyzed th and the biomarkers o M1 and M2 macrophages.”
BackgroundMethodInfluentialMolecular Crosstalk between Chromatin Remodeling and Tumor Microenvironment in Multiple Myeloma
Chakraborty, C., & Mukherjee, S. (2022) · Current Oncology · doi:10.3390/curroncol29120749 · Cited by 7
Updates on Tumor Biology in Vestibular Schwannoma
Nourbakhsh, A., & Dinh, C. T. (2023) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2023.02.004 · Cited by 7
Bryan, A., Pingali, P., Joslyn, M., Li, H. Y., Bernaś, T., Koblinski, J. E., Landry, J. W., Lee, W. S., Patel, B. B., & Neuwelt, A. J. (2023) · Cancers · doi:10.3390/cancers15194770 · Cited by 8
“M1 macrophages are characterized by the metabolism of arginine to nitric oxide via iNOS (inducible nitric oxide synthase), contributing to a tumor-suppressive pro-inflammatory microenvironment [10].”
BackgroundFan, X., Yan, Z.-J., Lin, Y., Wang, Q., Li, J., Yao, X., Dong, L., Chen, L., Zhao, T., Zhao, J., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03652-2 · Cited by 7
“It promotes Th2 response, wound healing and tissue regeneration [28].”
BackgroundZou, H., He, L., Hue, Z., Liu, M., Yao, S., Zhu, Y., Wang, Z., & Wang, Y. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04781-4 · Cited by 7
“In recent years, MCP-1 has been found to be essential for the recruitment and polarization of tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) (Boutilier and Elsawa 2021), and the nature of tumor cells and the interaction between tumor cells and stromal cells determine the expression levels of M…”
BackgroundTumor microenvironment as a novel therapeutic target for lymphoid leukemias
Mousavi, S., Nouri, S., Sadeghipour, A., & Atashi, A. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06237-w · Cited by 6
“In response to TME signals, a dynamic process known as "macrophage polarization" that converts M1 into M2 takes place [29].”
Topology-dependent T 2 relaxivity in Fe 3 O cluster-based MOFs for enhanced tumor monitoring via MRI
Wang, Q., Gong, Y., Li, J., Luo, D., Zeng, X., Ling, Y., Zhou, Y., & Chen, Z. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02858a · Cited by 6
Pan, X., Zheng, H.-F., Li, M.-C., Dong, K., Tang, Y., Chen, J., Yang, T., Liu, J.-G., Liu, Z.-C., Liu, Y., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010898 · Cited by 8
“All authors approved of the version to be published and agreed to be accountable for all aspects of the work.”
TAMs: Guardians or foes? Overcoming heterogeneity and delivery barriers for precision immunotherapy
Liang, X., Bai, R., Sun, Y., Ma, P., Lü, X., Han, T., & Guan, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115195 · Cited by 6
Decoding neutrophil extracellular traps and key gene drivers in unexplained pregnancy loss
Ding, H., Zhang, L., Yang, W., Liu, Y., Wang, C., Liu, L., Li, C., Pan, L., Chen, L., & Liu, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1628337 · Cited by 7
“M2 macrophages, activated by IL-4 and IL-13, secrete anti-in fl ammatory cytokines such as IL-10, IL-4, and transforming growth factor-b (TGF-b ), inhibit T cell proliferation and activation, and participate in Th2 immune responses, aiding tissue repair and angiogenesis (48, 49).”
Research advances in enhancing wound healing through exosome-induced macrophage reprogramming
Wang, H., Wu, H., Han, Y., & Guo, L. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152787 · Cited by 7
USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis
Lusardi, M., Rapetti, F., Spallarossa, A., Massone, M., Cichero, E., & Brullo, C. (2025) · Molecules · doi:10.3390/molecules30204038 · Cited by 8
“On the contrary, M2 macrophages are involved in cell proliferation, angiogenesis, and metastasis, and they are abundant when the tumor environment is already established [145].”
Oncolytic virus therapy for osteosarcoma: mechanisms, opportunities, and challenges
Wang, J., Ge, X., Liu, J.-H., & Zhang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1724768 · Cited by 9
Qiu, Z., Wang, R.-Y., Zhang, Y., Huang, H.-B., He, R.-Y., Yan, H., Luo, P., Yang, B., Xu, Z.-F., & He, Q.-J. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01729-x · Cited by 9
Fu, X., Zhang, H., Liu, W., Wu, T.-T., & Zheng, Y.-Z. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102956 · Cited by 6
“Under hypoxic stress, tumor cells secrete exosomes enriched in miR-301a, which drive the polarization of tumor-associated macrophages (TAMs) toward a pro-tumorigenic M2 phenotype via activation of the PTEN/PI3K γ signaling pathway [10 – 14].”
Alexander, E., Ning, Q., Xie, X., Zhao, X., Zhang, Y., Cheng, C., Shao, D., & Leong, K. W. (2026) · ACS Nano · doi:10.1021/acsnano.5c21823 · Cited by 6
Batchu, S., Gill, A. S., & Karsy, M. J. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.01.063 · Cited by 6
Modulatory role of neuropeptide FF system in macrophages
Wang, Y. X., Zuo, Z., Shi, J., Fang, Y., Yin, Z., Wang, Z., Yang, Z., Jia, B., & Sun, Y. (2024) · Peptides · doi:10.1016/j.peptides.2024.171164 · Cited by 9
Chen, Q., Chen, J., Lu, Z., Nian, R., Li, W., Yao, Z., Mou, S., Liu, Y., Cao, X., He, W., et al. (2024) · Discover Oncology · doi:10.1007/s12672-024-00913-5 · Cited by 6
“…our results also revealed a strong relationship between LAYN expression and TAM/M2 macrophage infiltration in HPV-negative HNSCC. Macrophages can be classified into two subtypes, M1 macrophages and M2 macrophages, based on their functions and levels of inflammatory cytokine secretion [35].”
ResultYu, J., Huang, L., & Cao, L. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.6.13 · Cited by 6
“Multiple studies related to CESC have shown that M2-polarized macrophages (M2φ) promote tumor growth and metastasis [4].”
BackgroundNiu, L. N., Chen, T., Yang, A., Yan, X., Jin, F., Zheng, A., & Song, X. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189125 · Cited by 7
A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma
Qin, L., Li, Y., Zeng, R., He, Y., Chen, X., Xiao, L., & Zhou, H. H. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2408088 · Cited by 7
“12 It has been reported that targeting CD47 may alter the behavior of resident M2 macrophages to inhibit tumor growth.”
BackgroundMicrobiome interactions: Acinetobacter baumannii biofilms as a co-factor in oral cancer progression
Pathoor, N. N., Ganesh, P. S., & Gopal, R. K. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04208-3 · Cited by 7
“In macrophages, the biofilm initially promotes polarization towards a pro-inflammatory M1 phe - notype, but over time, it shifts to an immunosuppressive M2 phenotype, aiding tumor progression (Boutilier and Elsawa 2021; Fu et al. 2023 ).”
Wang, S., Wang, Y., Guan, L.-S., Shen, A., Huang, R.-J., Yuan, S., Xiao, Y.-L., Wang, L., Lei, D., Zhao, Y., et al. (2025) · BMC Medical Genomics · doi:10.1186/s12920-024-02082-4 · Cited by 7
“…exert their pro-inflammatory effects by secreting cytokines such as IL-12 and IL-23, which contribute to the promotion of Th1 response (Th1 response refers to a specific type of immune response mediated by T-helper cells, particularly Th1 cells) [29–32] and cytotoxicity against tumor cells [33].”
LILRB4 as a novel immunotherapeutic target for multiple diseases
Wang, X., Li, L., Liu, D., Jin, Y., Zhao, X., Li, S., Hou, R., Guan, Z., Ma, W., Zheng, J., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116762 · Cited by 6
Beder, N., Mirbahari, S. N., Belkhelfa, M., Mahdizadeh, H., & Totonchi, M. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002294 · Cited by 7
Dihydroartemisinin inhibits lung cancer bone metastasis by modulating macrophage polarization
Hang, G., Gu, X., Gu, Y., Gan, P., Hua, C., & Chen, A. (2025) · European journal of medical research · doi:10.1186/s40001-025-02467-w · Cited by 6
“Conversely, M2 macrophages have restricted antigen presentation abilities, promoting tumor growth and progression by suppressing immune responses [10].”
Tumor-associated neutrophils in breast cancer: an angel or a devil?
Wen, S., Feng, T., & Fan, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1593156 · Cited by 6
“IL-6 produced by TANs upregulates PD-L1 through STAT3 pathway activation, synergizing with immune checkpoint molecules such as PD-L1 and Tim-3 expressed by TAMs to further suppress T cell activity (35).”
Wang, L., Jiaojiao, M., Xinyao, L., Tang, J., Zhe, S., Yu, X., Xinyi, L., Taulier, N., Yang, D., & Zhang, B. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114189 · Cited by 6
Ferroptosis-induced immune modulation: a new frontier in glioblastoma therapy
Rahaman, S., Vohora, D., & Kamal, Ä. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-04988-5 · Cited by 6
Kaur, J., Raza, K., & Preet, S. (2022) · Journal of Microencapsulation · doi:10.1080/02652048.2022.2149871 · Cited by 6
“Repolarization of TAMs plays a vital role in normalising irregular tumour growth and apoptosis (Boutilier and Elsawa 2021).”
BackgroundResultInfluentialRole of macrophage polarization in cancer progression and their association with COVID-19 severity
Thakur, A., Banerjee, R., Thakur, S., Kumar, G., & Thakur, S. S. (2023) · Cancer Insight · doi:10.58567/ci02010005 · Cited by 8
“Moreover, M1 macrophages can also produce reactive oxygen species, which can damage tumor cells and induce apoptosis, thus aiding in tumor control.[29] Macrophage polarization plays a crucial role in cancer progression and the immune response to cancer.”
BackgroundMacrophage-Based Therapeutic Strategies in Hematologic Malignancies
Khalili, S., Zeinali, F., Fard, A. M., Taha, S. R., Naghibi, A. F., Bagheri, K., Zadeh, M. S., Eslami, Y., Fattah, K., Asadimanesh, N., et al. (2023) · Cancers · doi:10.3390/cancers15143722 · Cited by 6
“TAMs play a substantial role in the metastatic process by contributing to invasion, angiogenesis, intravasation, extravasation, colonization, survival of tumor cells, induction of hypoxia, and pre-metastatic niche formation [2,56,59].”
BackgroundAbdi, H., Arabi, L., Montazer, M., Askarizadeh, A., Zamani, P., Hosseinzadeh, H., Jaafari, M. R., & Mosaffa, F. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121992 · Cited by 6
Unleashing the pathological imprinting of cancer in autoimmunity: Is ZEB1 the answer?
Rithvik, A., Samarpita, S., & Rasool, M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122115 · Cited by 8
Dai, W., Mo, W., Xu, W., Han, D., & Xu, X. (2023) · Aging · doi:10.18632/aging.205079 · Cited by 6
“Whereas Macrophages M2 generally have tumor-promoting effects [42–44], implying a worse prognosis.”
BackgroundTherapeutic applications of carbon nanomaterials in renal cancer
Priyam, J., & Saxena, U. (2023) · Biotechnology Letters · doi:10.1007/s10529-023-03429-0 · Cited by 6
“M2-polarized macrophages are involved in pro-tumourigenic processes, including immune suppression, hypoxia-induced tumour growth, angiogenic regulation, and metastasis (Boutilier and Elsawa 2021).”
BackgroundLi, Q., Huang, X., & Zhao, Y. (2023) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2023.0103 · Cited by 6
“30 Hence, the low level of immune cell infiltration and immunosuppressive TME may exist in solid OS, possibly partly accounting for the low survival rates of high-risk OS patients.”
Ubiquitin signaling in pancreatic ductal adenocarcinoma
Lv, S., Zhang, J., Peng, X., Liu, H., Liu, Y., & Wei, F. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1304639 · Cited by 7
“…fi ltrating into the TME, tumor-associated macrophages (TAMs) are of signi fi cant importance as they can be polarized into the pro-in fl ammatory subtype M1 or the anti-in fl ammatory subtype M2, with M1 inhibiting and M2 promoting the tumor progression (Boutilier and Elsawa, 2021; Wang et al., 2021).”
BackgroundYang, Y., Zhao, C., Yang, Z., Du, C., Chang, Z., Wen, X., Zhang, X., liu, Y., Hu, L., & Gao, Z. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02447-3 · Cited by 7
“Both M1 and M2 polarization of macrophages are known to be closely related to inflammatory responses [29, 30].”
BackgroundEmerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
Wu, J. D. (2024) · BioDrugs · doi:10.1007/s40259-024-00657-2 · Cited by 8
“When appropriately stimulated, TAMs can repolarize into immune-activating macrophages to orchestrate antitumor responses through phagocytosis to directly kill tumor cells, presenting antigens to CD8 T cells, or secreting cytokines/chemokines for NK and CD8T cell recruitment [87-89].”
BackgroundChen, H., Li, J., Cao, D., & Tang, H. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s453080 · Cited by 8
“18,19 Therefore, it is essential to identify genes and biomarkers related to tumor-associated macrophage polarization for the effective treatment and prognosis of HCC.”
BackgroundFu, Q., Lu, Z., Chang, Y., Jin, T., & Zhang, M. (2024) · Industrial Crops and Products · doi:10.1016/j.indcrop.2024.119589 · Cited by 6
Reprogramming tumor-associated macrophages: The role of MEK-STAT3 inhibition in lung cancer
Rawat, S., Moglad, E. H. O., Afzal, M., Goyal, A., Roopashree, R., Bansal, P., Mishra, S., Prasad, G. V. S., Pramanik, A., Alzarea, S. I., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155748 · Cited by 6
Bai, J., Chen, P., Zhou, Q., Tie, X., Xiao, X., Wang, Y., & Jin, L. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102714 · Cited by 6
Yang, L., Gui, J., Sheng, Y., Liu, J., Wang, C., Fang, Z., Huang, L., Tu, Z., Zhu, X., & Huang, K. (2025) · European journal of medical research · doi:10.1186/s40001-025-02360-6 · Cited by 7
Wang, M., Qiao, L., Jin, L., Chen, Y., Wen, X., & Wang, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144057 · Cited by 8
RetractedLacerda, P. A., Oenning, L., Bellato, G. C., Lopes-Santos, L., Antunes, N. D. J., Mariz, B. A. L. A., Teixeira, G., Vasconcelos, R., Simões, G. F., de Souza, I. A., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1098374 · Cited by 6
“The TME can influence macrophage recruitment and polarization, giving way to these pro-tumorigenic outcomes; (Boutilier and Elsawa, 2021); thus, investigating TME-induced macrophage polarization is critical for further understanding TAM-related pro-tumor outcomes and the potential development of new therapeutic approa…”
BackgroundYang, Y., Yan, C., & Chen, X. (2023) · BMC Oral Health · doi:10.1186/s12903-023-03421-0 · Cited by 6
“It is well known that M2 macrophages are among the most important cells in the tumor micro-environment that promote cancer progression [52, 53].”
BackgroundEngineering transcriptional regulation for cell-based therapies
Recktenwald, M., Hutt, E., Davis, L., MacAulay, J., Daringer, N. M., Galie, P. A., Staehle, M. M., & Vega, S. L. (2024) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2024.100121 · Cited by 6
Li, S., Wang, C., Tang, Y., Qin, L., Chen, T., Wang, S., Bai, Y., Cai, X., & Wang, S. (2023) · Microorganisms · doi:10.3390/microorganisms11010160 · Cited by 6
“Macrophages are major regulators of inflammation, and can polarize into different phenotypes based on perceived stimuli [22,23].”
BackgroundKhanduri, I., Maki, H., Verma, A., Katkhuda, R., Anandappa, G., Pandurengan, R. K., Zhang, S., Mejia, A., Tong, Z., Soto, L. M. S., et al. (2024) · BJC Reports · doi:10.1038/s44276-024-00056-8 · Cited by 7
“In summary, ours is one of the fi rst studies to quantify macrophages and analyze the prognostic signi fi cance of macrophage polarization in CLM using multiplex immuno fl uorescence.”
MethodIL-4-Induced Gene 1: A Potential Player in Myocardial Infarction
Shen, R. D., Ding, Y., Dong, Q., Wang, Y., Yu, J. Y., Pan, C., Cai, Y., Li, Z., Zhang, J., Yu, K., et al. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2509337 · Cited by 5
“Strikingly, tumor-associated macrophages, which invade tumor tissue and are generally considered M2 type, were found to express the immunosuppressive enzyme IL4I1 in numerous cancers [ 24,58].”
BackgroundMulti-omics joint screening of biomarkers related to M2 macrophages in gastric cancer
Wang, X., & Zhang, Y. (2024) · Discover Oncology · doi:10.1007/s12672-024-01623-8 · Cited by 6
Cui, G., Liu, W., Sun, X., Bai, Y., Ding, M., Zhao, N., Guo, J., Qu, D., Wang, S., Qin, L., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138523 · Cited by 5
RetractedJędrzejewski, T., Sobocińska, J., Maciejewski, B., Spisz, P., Walczak‐Skierska, J., Pomastowski, P., & Wrotek, S. (2024) · Immunologic Research · doi:10.1007/s12026-024-09574-6 · Cited by 5
“Moreover, this phenotype of macrophages is positively associated with the survival time of cancer patients and more favourable clinical outcomes in many cancers, such as small cell lung cancer, colorectal cancer, ovarian cancer, and TNBC [9].”
Simon, A. G., Lyu, S. I., Schultheis, A. M., Stahl, D. J., Wuerdemann, N., Walter, S. G., Hieggelke, L., Büttner, R., Bruns, C. J., Eysel, P., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.35310 · Cited by 7
Application of Macrophage Subtype Analysis in Acute Lung Injury/Acute Respiratory Distress Syndrome
Tang, J., Shi, J., Han, Z., & Chen, X. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2912412 · Cited by 7
“For instance, M1 and M2 macrophages can be distinguished based on distinct patterns of surface receptor expression, secretion profiles, and functional characteristics [15,81,82].”
Metadata
- Authors
- Boutilier, A. J., & Elsawa, S. F.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- Elsawa, Sherine F.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 6995
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8268869
- OpenAlex
- W3173665490
- Cited by
- 1,631
- References
- 148
- Citations by year
- 2026: 281 · 2025: 409 · 2024: 429 · 2023: 359 · 2022: 144 · 2021: 9
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P20 GM113131)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- macrophage polarization, tumor-associated macrophages, tumor microenvironment, tumor progression, angiogenesis, lymphangiogenesis, immunosuppression, hypoxia, metastasis, macrophage recruitment
- MeSH terms
- Tumor-Associated Macrophages, Animals, Hypoxia, Cell Transformation, Neoplastic, Humans, Inflammation, Macrophage Activation, Neoplasm Metastasis, Neoplasm Staging, Signal Transduction, Biomarkers, Immunophenotyping, Cytokines, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.